Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-04-19FDA Approved: FLUOXETINE — Supplemental Application (TIME CAP LABORATORIES, INC.)
FDA approved a supplemental application for fluoxetine hydrochloride from Time Cap Laboratories, Inc., updating the regulatory status of thi…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: A Study in the Treatment of Children and Adolescents With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial update from Eli Lilly evaluating treatment for Major Depressive Disorder in children and adolescents; the study is co…
-
CLINICAL_TRIALS research · 2012-04-19Clinical Trial Update: Genetic Study of Liver Enzymes in Patients With Side Effects From Antidepressants
A completed genetic study examined liver enzyme variation in patients with major depressive disorder who experienced side effects from antid…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: eCare for Moods: An Internet-based Management Program [NA]
This clinical trial update reports the completion of the eCare for Moods internet-based management program trial for Major Depressive Disord…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Tai Chi Training for Treating Depressed Chinese Americans [NA]
Completed clinical trial evaluating Tai Chi training as a treatment for Major Depressive Disorder in Chinese American participants. Sponsor:…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-04-18FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder [Phase 4]
Phase 4 trial update evaluating duloxetine dosing strategies in Korean patients with major depressive disorder; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: The Efficacy of Parent Involvement in the Treatment of Adolescent Depression [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the impact of involving parents in the treatment of adolescents with major depressive disorder and re…
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Citalopram vs Clomipramine vs Placebo in Recurrent Depression [NA]
A completed trial comparing citalopram, clomipramine, and placebo for recurrent depression.
-
FDA approval · 2012-04-10FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for paroxetine hydrochloride submitted by Apotex Corp.
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: AZD7268 Safety and Tolerability Study [Phase 2]
Phase 2 safety and tolerability study of AZD7268 in major depressive disorder has been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder [Phase 2]
Phase 2 clinical trial update for SPD489 in adults with persistent executive function impairments and recurrent major depressive disorder; r…
-
CLINICAL_TRIALS research · 2012-04-05Clinical Trial Update: Evaluation of Pharmaceutical Care in Depressed Outpatients [NA]
Clinical trial update describing an evaluation of pharmaceutical care in outpatients with depression, sponsored by the Federal University of…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: SSRI and Buprenorphine [Phase 3]
Phase 3 trial of an SSRI in combination with buprenorphine for opioid dependence with comorbid depression has completed and results were pos…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse [Phase 4]
Phase 4 clinical trial evaluating pregnenolone for depression in individuals with bipolar disorder or recurrent major depressive disorder wi…
-
FDA approval · 2012-04-02FDA Approved: ESCITALOPRAM OXALATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves an original application for escitalopram oxalate as a generic drug, manufactured by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364) [Phase 4]
A Phase 4 trial evaluating desvenlafaxine succinate sustained-release (DVS SR) for peri- and postmenopausal women with major depressive diso…
-
CLINICAL_TRIALS withdrawal · 2012-03-29Clinical Trial Update: Omacor for Perimenopausal Depression [Phase 2]
Phase 2 trial evaluating Omacor for perimenopausal depression was withdrawn from the study.
-
FDA approval · 2012-03-28FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Bupropion Hydrochloride from Apnar Pharma LP, confirming approval of a generic formulation.
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Improving Depression Care for Elders: Coordinating Center [NA]
A completed clinical trial update from UCLA's Coordinating Center on improving depression care for elders.
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Can Vitamin D3 Supplementation Affect Treatment Outcomes in Patients With Depression [Phase 4]
A Phase 4 clinical trial update investigates whether vitamin D3 (cholecalciferol) supplementation affects treatment outcomes in depression.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's generic quetiapine tablets through an Original Application. Quetiapine is approved for schizophrenia, bipolar disorder, …
-
FDA approval · 2012-03-27FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, granting approval for a generic product under an A…
-
FDA approval · 2012-03-27FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Celexa (citalopram) submitted by Allergan, Inc.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Accord Healthcare Inc.)
FDA approved a generic Quetiapine product from Accord Healthcare Inc. under ANDA202152 (Original Application).